Search

Issue
Title
Authors
Fresh Platinum Complexes with Promising Antitumor Activity
Wang X.
Evaluation of Novel Benzo-annelated 1,4-dihydropyridines as MDR Modulators in Cancer Cells
Werner P., Szemerédi N., Spengler G., Hilgeroth A.
Structural Effects of TiO2 Nanoparticles and Doxorubicin on DNA and their Antiproliferative Roles in T47D and MCF7 Cells
Hekmat A., Saboury A., Divsalar A., Seyedarabi A.
Fragment-based Drug Discovery Successful Contributions to Current Pharmacotherapeutic Agents Arsenal against Aggressive Cancers: A Mini-Review
Santos L., da Silveira N.
In Vitro Synergistic Interaction between DTA0100 and Radiation in Human Cancer Cell Lines
Bordon E., G. Leon L., Rios-Luci C., C. Lara P., M. Padron J.
The Design and Characterization of a Novel beta-casein Nano-vehicle Loaded with Platinum Anticancer Drug for Drug Delivery
Divsalar A., Razmi M., Saboury A., Seyedarabi A.
The Use of Anthracyclines for Therapy of CNS Tumors
Ros M., Iorio A., Lucchesi M., Stival A., Martino M., Sardi I.
First Ayurvedic Approach Towards Green Drugs: Anti Cervical Cancer-Cell Properties of Clerodendrum viscosum Root Extract
Sun C., Nirmalananda S., Jenkins C., Debnath S., Balambika R., Fata J., Raja K.
Angiogenesis in Glioblastoma Multiforme: Navigating the Maze
G. Linkous A., M. Yazlovitskaya E.
Nanoparticles in Oncology: The New Theragnostic Molecules
Allegra A., Penna G., Alonci A., Rizzo V., Russo S., Musolino C.
Inhibitors of Cancer Stem Cells
García-Rubiño M., Lozano-López C., Campos J.
Using Cytochalasins to Improve Current Chemotherapeutic Approaches
Trendowski M.
Doxorubicin-Loaded Nanoparticles: New Advances in Breast Cancer Therapy
Prados J., Melguizo C., Ortiz R., Velez C., J. Alvarez P., L. Arias J., A. Ruiz M., Gallardo V., Aranega A.
Development of NGR-Based Anti-Cancer Agents for Targeted Therapeutics and Imaging
E. Wang R., Niu Y., Wu H., Hu Y., Cai J.
Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer – from Molecular Signalling to Clinical Trials
Falasca M., Selvaggi F., Buus R., Sulpizio S., E. Edling C.
Mechanisms of Drug Resistance to Vascular Endothelial Growth Factor (VEGF) Inhibitors
Tavakoli J., B. Aragon-Ching J.
Pioneering a New Era in Oral Cancer Treatment with Electrospun Nanofibers: A Comprehensive Insight
Tripathi D., Gupta T., Rai A., Pandey P.
Potential of Nanomedicines as an Alternative for the Treatment of Colorectal Cancer - A Review
Nicolau Costa K., Barros L.A., da Silva Soares I.L., Oshiro-Junior J.A.
Liposomal Nano-Based Drug Delivery Systems for Breast Cancer Therapy: Recent Advances and Progresses
Yazdan M., Naghib S.M., Mozafari M.R.
Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia
Shah K., Mirza S., Desai U., Jain N., Rawal R.
Review of Procedures Used for the Extraction of Anti-Cancer Compounds from Tropical Plants
Pandey S., Shaw P., Hewavitharana A.
NF-κB Down–regulation and PARP Cleavage by novel 3-α-butyryloxy-β-boswellic Acid Results in Cancer Cell Specific Apoptosis and in vivo Tumor Regression
Qurishi Y., Hamid A., Sharma P.R., Wani Z.A., Mondhe D.M., Singh S.K., Zargar M.A., Andotra S.S., Shah B.A., Taneja S.C., Saxena A.K.
Targeting Cancer Using Fragment Based Drug Discovery
P. Turnbull A., M. Boyd S.
Combination Therapy for the Treatment of Pancreatic Cancer
Greenhalf W., Thomas A.
Capivasertib: First Approved AKT inhibitor for the Treatment of Patients with Breast Cancer
De S.
Surface Modification of Poly(lactide-co-glycolide) Nanoparticles for the Sustained in vitro Release and the Enhanced Cytotoxicity of Chelidonine
Hamidia Z., Shahanipour K., Talebian N., Monajemi R.
Identification of Novel EGFR Inhibitors for the Targeted Therapy of Colorectal Cancer Using Pharmacophore Modelling, Docking, Molecular Dynamic Simulation and Biological Activity Prediction
Krishnan K. A., George Valavi S., Joy A.
1,3-Diaryl Triazenes Incorporating Disulfonamides Show Both Antiproliferative Activity and Effective Inhibition of Tumor-associated Carbonic Anhydrases IX and XII
Lolak N., Akocak S., Petreni A., Budak Y., Bozgeyik E., Gurdere M., Ceylan M., Supuran C.
Generation of Redox Imbalance Mediates the Cytotoxic Effect of Malabaricone-A in a Multidrug Resistant Cell Line
Manna A., Bauri A., Chattopadhyay S., Chatterjee M.
Hypersensitivity to Aurora Kinase Inhibitors in Cells Resistant against Platinum- Containing Anticancer Agents
Akiyama M., Izumi H., Wang K., Yamaguchi T., Kuma A., Kitamura N., Harada Y., Oya R., Yamaguchi K., Iwai Y., Kohno K.
Human Skin-Derived Fibroblasts Acquire In Vitro Anti-Tumor Potential after Priming with Paclitaxel
Pessina A., Cocce V., Bonomi A., Cavicchini L., Sisto F., Ferrari M., Ciusani E., Navone S., Marfia G., Parati E., Alessandri G.
Fig Latex (Ficus carica L. cultivar Dottato) in Combination with UV Irradiation Decreases the Viability of A375 Melanoma Cells In Vitro
Menichini G., Alfano C., Provenzano E., Marrelli M., A. Statti G., Somma F., Menichini F., Conforti F.
Atypical GTPases as Drug Targets
Soundararajan M., Eswaran J.
Anti-Proliferative Activity of Synthetic Ajoene Analogues on Cancer Cell-Lines
H. Kaschula C., Hunter R., T. Hassan H., Stellenboom N., Cotton J., Q. Zhai X., Iqbal Parker M.
Recent Researches in Metal Supramolecular Complexes as Anticancer Agents
Zhou C., Zhang Y., Yan C., Wan K., Gan L., Shi Y.
PEGylated Titanium Dioxide Nanoparticle-bound Doxorubicin and Paclitaxel Drugs Affect Prostate Cancer Cells and Alter the Expression of DUSP Family Genes
Tuncbilek Z., Cakmak N., Tas A., Ayan D., Silig Y.
Osimertinib Induces the Opposite Effect of Proliferation and Migration in the Drug Resistance of EGFR-T790M Non-small Cell Lung Cancer Cells
Wang R., Chang C., Chen C., Liu K., Chao J.
Overview of the New Bioactive Heterocycles as Targeting Topoisomerase Inhibitors Useful Against Colon Cancer
Santos M., de Azevedo Teotônio Cavalcanti M., de Medeiros e Silva Y.M., dos Santos Nascimento I., de Moura R.
Recent Advance in Drug Development of Squamous Cell Carcinoma
Lei J., Fu B., Yin H., Tang G., Zhu S., Yan C., He Q.
Multifunctionalized Microbubbles for Cancer Diagnosis and Therapy
Li H., Wang J., Huang G., Wang P., Zheng R., Zhang C., Jiang Q.
Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization
Shen M., Hang Chan T., Ping Dou Q.
Ceramide-Based Therapeutics for the Treatment of Cancer
M. Barth B., C. Cabot M., Kester M.
TEM8 Targeted Cancer Therapy
E. Frankel A., Carter C., Kuo S., Woo J., Mauldin J., Liu J.
Enzyme Inhibition as a Key Target for the Development of Novel Metal-Based Anti-Cancer Therapeutics
Griffith D., P. Parker J., J. Marmion C.
In silico-driven identification of Pranlukast as a Stabilizer of PD-L1 Homodimers
Cordova-Bahena L., Landero-Marin C., Flores-Hernandez X., Alvarez-Coronel L., Jimenez-Uribe A., Salinas-Jazmin N., An Z., Velasco-Velazquez M.
Glioblastoma as a Novel Drug Repositioning Target: Updated State
Hosseinalizadeh H., Ebrahimi A., Tavakoli A., Monavari S.
The Potential Role of Non-coding RNAs in Regulating Ferroptosis in Cancer: Mechanisms and Application Prospects
Cao M., Zhang Z., Hou X., Wang X.
The Interactions of Anticancer Agents with Tea Catechins: Current Evidence from Preclinical Studies
Shang W., Lu W., Han M., Qiao J.
Anticancer Effects of the Organosilicon Multidrug Resistance Modulator SILA 421
Olszewski U., Zeillinger R., Demirel Kars M., Zalatnai A., Molnar J., Hamilton G.
Sphingolipid Metabolism and Drug Resistance in Hematological Malignancies
Gouaze-Andersson V., C. Cabot M.
Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates
A. Kudgus R., Bhattacharya R., Mukherjee P.
A Better Platinum-Based Anticancer Drug Yet to Come?
Olszewski U., Hamilton G.
Molecular Dynamics (MD) Simulation of GPR87-LPA Binding: Therapeutic Implications for Targeted Cancer Treatment
Rani M., Sharma A., Nischal A., Khattri S., Sahoo G., Singh R.
Carbon Nanotubes in the Diagnosis and Treatment of Malignant Melanoma
Naderi N., Y. Madani S., Ferguson E., Mosahebi A., M. Seifalian A.
Preparation of a Novel Multifunctional Cationic Liposome Drug-carrying System and its Functional Study on Lung Cancer
Kong Y., Xu L., Cao J.
Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge
Yousefi B., Zarghami N., Samadi N., Majidinia M.
Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics
Arkwright R., Deshmukh R., Adapa N., Stevens R., Zonder E., Zhang Z., Farshi P., Ahmed R., El-Banna H., Chan T., Dou Q.
Nonsteroidal Aromatase Inhibitors for the Treatment of Breast Cancer: An Update
Gobbi S., Rampa A., Belluti F., Bisi A.
New Insight into P-Glycoprotein as a Drug Target
Breier A., Gibalova L., Seres M., Barancik M., Sulova Z.
Drug Targeting Strategies for Photodynamic Therapy
Schmitt F., Juillerat-Jeanneret L.
Protein Phosphatase 2A as a Potential Target for Anticancer Therapy
Kalev P., A. Sablina A.
Latest Insights into the Anticancer Activity of Gold(III)-Dithiocarbamato Complexes
Ronconi L., Aldinucci D., Ping Dou Q., Fregona D.
Optimized Rutin-incorporating PEGylated Nanoliposomes as a Model with Remarkable Selectivity Against PANC1 and MCF7 Cell Lines
Al-Samydai A., Al Qaraleh M., Al-Halaseh L., Abu Hajleh M., Carradori S., Abdulmaged M., Kareem R., Alzaidi H., Mousa M., Al-Hiari Y., Nsairat H., Alshaer W.
Nonsteroidal Aromatase Inhibitors for the Treatment of Breast Cancer: An Update
Gobbi S., Rampa A., Belluti F., Bisi A.
Molecular Mechanisms of Anti-cancer Activities of β-elemene: Targeting Hallmarks of Cancer
Jiang S., Ling C., Li W., Jiang H., Zhi Q., Jiang M.
Combined Anticancer Therapies: An Overview of the Latest Applications
Piccolo M., Menale C., Crispi S.
Discovery of P3971 an Orally Efficacious Novel Anticancer Agent Targeting HIF-1α and STAT3 Pathways
Godse P., Kumar P., Yewalkar N., Deore V., Lohar M., Mundada R., Padgaonkar A., Manohar S., Joshi A., Bhatia D., Desai N., Damre A., Bhonde M., Joshi K., Sharma R., Kumar S.
Cytoskeletal Alterations that Confer Resistance to Anti-tubulin Chemotherapeutics
Kanakkanthara A., H. Teesdale-Spittle P., H. Miller J.
Procathepsin D as a Tumor Marker, Anti-Cancer Drug or Screening Agent
Vetvicka V., Fusek M.
ABC Transporters: Unvalidated Therapeutic Targets in Cancer and the CNS
W. Robey R., R. Massey P., Amiri-Kordestani L., E. Bates S.
Lung Cancer Stem Cells as a Target for Therapy
Gorelik E., Lokshin A., Levina V.
Evaluation of Novel Diaza Cage Compounds as MRP Modulators in Cancer Cells
Döring H., Kreutzer D., von Veh J., Ritter C., Hilgeroth A.
Drug Repositioning for Ovarian Cancer Treatment: An Update
Cavalluzzi M., Viale M., Rotondo N., Ferraro V., Lentini G.
Antidepressant Sertraline Hydrochloride Inhibits the Growth of HER2+ AU565 Breast Cancer Cell Line through Induction of Apoptosis and Cell Cycle Arrest
Fayyaz S., Atia-Tul-Wahab , Irshad R., Siddiqui R., Choudhary M.
Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery
Pinheiro A., Mendonça Nogueira T., de Souza M.
Mesenchymal Stromal Cells Uptake and Release Paclitaxel without Reducing its Anticancer Activity
Parati E., Alessandri G., Bagnati R., Pessina A., Mariotti M., Colognato R., Rimoldi M., Rizzetto M., Sisto F., Cocce V., Bonomi A.
Colon Cancer Therapy: Recent Developments in Nanomedicine to Improve the Efficacy of Conventional Chemotherapeutic Drugs
Prados J., Melguizo C., Ortiz R., Perazzoli G., Cabeza L., Álvarez P., Rodriguez-Serrano F., Aranega A.
Rational Drug Design for Identifying Novel Multi-target Inhibitors for Hepatocellular Carcinoma
Temirak A., Abdulla M., Elhefnawi M.
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance
S. Gayle S., L.M. Arnold S., M. O'Regan R., Nahta R.
Development of Focal Adhesion Kinase Inhibitors in Cancer Therapy
Wee Ma W.
The Interactions of Anti-Cancer Drugs Approved in the Last Decade in the United States with Membrane Transporters
Jain L., Abraham S., S. Shord S.
Anticancer Activities and Mechanisms of Bisdioxopiperazine Compounds Probimane and MST-16
Lu D., Lu T.
An Antidepressant Drug Increased TRAIL Receptor-2 Expression and Sensitized Lung Cancer Cells to TRAIL-induced Apoptosis
Zinnah K., Newaz Munna A., Seol J., Park B., Park S.
Cervical Cancer Therapeutics: An In-depth Significance of Herbal and Chemical Approaches of Nanoparticles
Saraswat I., Goel A.
Improving Tamoxifen Performance in Inducing Apoptosis and Hepatoprotection by Loading on a Dual Nanomagnetic Targeting System
Zhao Y., Ding W., Zhang P., Deng L., Long Y., Lu J., Shiri F., Heidari Majd M.
1 - 85 of 85 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"